Demonstrates enhanced mRNA capping efficiency in a continuous synthesis process, suggesting improvements for manufacturing.
Efficient synthesis of cap-1 mRNA is limited by low recovery and degradation risks in conventional multistep enzymatic reactions which require multiple intermediate separations. Here, we execute a mechanism-driven one-pot multienzyme cascade catalyzed by T7 RNA polymerase (T7-RNAP), vaccinia capping enzyme (VCE), and 2′-O-methyltransferase (2′-O-MTase) for continuous synthesis of cap-1 mRNA, where competitive interactions between Mg2+ and VCE activity are deciphered. It is generally regarded that excess Mg2+ promotes transcription but suppresses the capping; however, in our integrated cascade system, VCE exhibits largely enhanced tolerance to Mg2+, which was uncovered due to the competitive binding effects of the transcription complex consisting of linearized plasmid DNA and T7-RNAP. By combining this mechanistic insight with programmed temperature regulation, we reconciled the conflicting requirements of IVT synthesis and capping of mRNA: temperature optimally balances T7-RNAP/VCE activity and 5′-end mRNA accessibility, while Mg2+ plays a manifold role in the mRNA folding, Mg2PPi precipitation, transcription complex formation, and VCE-Mg-GTP activation. Importantly, our results demonstrate that supplementing Mg2+ not only sustains the IVT reaction but also improves the capping efficiency without intermediate purification. These findings provide mechanistic insights into multienzyme incompatibility and its resolution, offering a promising application in continuous mRNA manufacturing with high efficiency at reduced process cost.
No takes yet. Share an insight, caveat, or question.
Che et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: